Crossmark

Rome III and IV criteria are less discordant to diagnose irritable bowel syndrome in clinic patients than in community subjects

Published Online: 2024-06-29

Published Print: 2024-12

Authors

Ghoshal, Uday C. https://orcid.org/0000-0003-0221-8495
Mustafa, Uzma

Pandey, Vipin Kumar
License Information

Text and Data Mining valid from 2024-06-29

Version of Record valid from 2024-06-29
More Information

Article History

Received: 1 April 2024

Accepted: 13 May 2024

First Online: 29 June 2024

Declarations

:

: UCG has patents and applications for indigenous radio-opaque markers for colon transit study, double-lumen catheter for upper gut aspirate culture, FODMAP fermentation chamber, BreathCalc and FODMAP meal challenge test. None of the other authors declare any conflict of interest concerning this paper.

: The study protocol was approved by the Institutional Ethics Committee (IEC code: 2018–207-EMP-107) and each patient provided written informed consent. The study was performed in a manner to conform with the Helsinki Declaration of 1975, as revised in 2000 and 2008 concerning human and animal rights, and the authors followed the policy concerning informed consent as shown on Springer.com.

: The authors are solely responsible for the data and the content of the paper. In no way, the Honorary Editor-in-Chief, Editorial Board Members, the Indian Society of Gastroenterology or the printer/publishers are responsible for the results/ findings and content of this article.

Document is current